Supplementary Table 1 from Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape

Open Access

Publisher Website

30 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/0008-5472.22389071.v1

Abstract

Supplementary Table 1 from Glioblastoma Recurrence after Cediranib Therapy in Patients: Lack of “Rebound” Revascularization as Mode of Escape

Keywords